A quality Improvement Project to Standardize Pain, Agitation, and withdrawal Assessments Reduces Usage of Morphine and Midazolam in the Pediatric Intensive Care Unit
CCCF ePoster library. Zavalkoff S. Nov 7, 2018; 234188
Dr. Samara Zavalkoff
Dr. Samara Zavalkoff
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)

Introduction: Sedation in critically ill patients is often suboptimal. With over-sedation, it increases risk for iatrogenic withdrawal syndrome, delirium and may be associated with long term neurological impairment. Recent guidelines recommend that pain and sedation in critically ill children should be assessed and titrated sedatives and analgesics accordingly. We conducted a QI project to implement a routine standardized assessment of pain, agitation and withdrawal in our PICU

Objectives: To assess the impact of a quality improvement (QI) initiative to increase assessments of pain, agitation, and withdrawal on the use and cost of sedative and analgesic medication in a pediatric intensive care unit (PICU).

Methods:

Design: Retrospective pre- and post- quality improvement study.

Setting: Eighteen-bed medical-surgical-cardiac tertiary PICU in an academic center.

Patients: PICU patients (0 - 18 years) consecutively admitted from October 1, 2015 to March 31, 2016 (pre- period) and from October 1, 2016 to March 31, 2017 (post- period) who were mechanically ventilated (MV) for more than 48 hours.

Intervention: QI initiative developed by a multidisciplinary team, including a family advisor, and implemented using rapid “Plan-Do-Study-Act cycles”, that 1) standardized assessment of pain and sedation, 2) standardized sedation goal setting, and 3) implemented the use of non-pharmacological strategies to manage pain and sedation. No specific sedation protocol was implemented. We used audit and feedback to reinforce change.

Measurements and main results: The post-intervention phase started once > 60% of patients had documented sedation scores q12h. Forty-five patients were included in each group. The groups were similar in age, weight, sex, PRISM III, and MV-day, but different in PICU stay (8 vs. 12 days, p 0.047). The cumulative dose of midazolam equivalent was significantly lower in the post-implementation period (3.71 vs 2.65 mg/kg/MV-day, p 0.009). There was a decreasing trending in morphine equivalent usage (3.51 vs 2.57 mg/kg/MV-day, p 0.066). There were no significant pre-post differences in the use of other sedative agents, rate of withdrawal, or medication cost.

Conclusions: A multi-faceted QI project to standardize formal assessments of pain and agitation resulted in a significant reduction in midazolam use. We also observed a decrease in morphine use without increasing rates of iatrogenic withdrawal syndrome.

 


    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings